from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1820/ilvG

LFCtreatmentdescriptionclass of inhibitor

-0.011

Amikacinug/mL Amikacintranslation

-0.427

Cap5-10ug/mL Capreomycintranslation

0.410

Rox10-50 ug/mL Roxithromycintranslation

-0.017

SM2-5 ug/mL Streptomycintranslation

0.791

Tet5-10 ug/mL Tetracyclinetranslation

0.280

Rif0.2-5ug/mL Rifampicintranscription

-0.168

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.879

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.181

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.159

CPZ10-50 ug/mL Chlorpromazinerespiration

0.387

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.338

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.152

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.401

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.625

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.422

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.378

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.201

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.346

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.119

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.344

KCN5-20 ug/mL Potassium cyaniderespiration

0.497

NaN30.2-2 mM Sodium aziderespiration

-1.201

Nigericin50 uM Nigericinrespiration

0.159

TRC10-150 ug/mL Triclosanrespiration

0.971

TRZ10-25 ug/mL Thioridazinerespiration

-0.679

Valinomycin0.5-10 uM Valinomycinrespiration

1.082

ZnSO42 mM ZnSO4respiration

0.131

menadione6-10 ug/mL Menadionerespiration

0.439

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.731

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.141

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.289

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.573

NRP_1Non-replicating persistence stage 1dosRassociated

-0.268

Amp0.2mg/mL AmpicillincellWall

-0.171

Cephalexin20-100 ug/mL CephalexincellWall

-0.001

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.302

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.480

EMB10-20 ug/mL EthambutolcellWall

0.512

Eta12-40 ug/mL EthionamidecellWall

0.430

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.248

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.606

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.668

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.042

BZA0.12 mg/mL BenzamidearomaticAmides

-0.621

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.334

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.164

H2O24 mM hydrogen peroxideDNAdamaging

-1.195

Levo10 ug/mL LevofloxacinDNAdamaging

-0.566

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.381

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.186

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.186

UVUV-irradiationDNAdamaging

0.594

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.551

Antimycin12.5-50 ug/mL Antimycin A?

-0.023

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.466

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.720

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.920

PA8240.2-2 ug/mL PA-824?

2.193

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.801

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.292

Verapamil50 uM Verapamil?

-0.245

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.442

methoxatin10-20 ug/mL Methoxatin?